Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > As the volume drops

<< Previous

Bullboard Posts

Next >>

Comment by GoldenHawkon Jun 21, 2018 9:06pm

130 Views

Post# 28209949

RE:As the volume drops

Your opinion is heard but doesn’t line up to the big picture, insiders buying, ICOs partner having a $3 stock and pending results on there way as noted in yesterdays news! Buyers will be strong in the morning and sellers weak, up she goes for a Friday record high!

Godfather wrote: So will the share price. The traders will move on, and there will be a lot of bagholders that bought near today's highs, that will realize there mistake and start dumping when the buying abates.

Low teens coming soon.

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?